Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Molbio Diagnostics logo — company profile

Molbio Diagnostics

Founded 2000 India Verna, India 588 employees Series Unknown Total: $2.49B Biotechnology, Health Care +2

General Information

Company Name Molbio Diagnostics
Founded Year 2000
Location India Verna, India +1
Employees 588
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage Series Unknown
Social

Get notified when Molbio Diagnostics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Molbio Diagnostics

Molbio Diagnostics is a disruptor in the global healthcare landscape, aiming to revolutionize point-of-care diagnostics. Founded in 2000 and headquartered in India, the company's vision is centered on universalizing access to precise, rapid, and cost-effective healthcare technologies. Renowned for its WHO-endorsed Truenat® real-time PCR platform, Molbio is at the forefront of providing cutting-edge solutions for quality healthcare delivery at the last mile. The company's focus on decentralizing and democratizing diagnostics through advanced portable platforms has attracted significant attention in the industry. In its most recent funding round, Molbio secured a substantial $85.00M in Venture Round investment on 26 September 2022. The investment was led by Temasek Holdings and Motilal Oswal Private Equity, signaling strong support from prominent investors. Molbio's efforts empower remote, resource-poor settings worldwide to implement sophisticated diagnostics for a wide range of diseases, from infectious diseases like TB and hepatitis to non-communicable diseases such as breast cancer, sickle cell disease, and diabetes. The company's diverse portfolio of tests further showcases its commitment to advancing healthcare accessibility and efficiency. With its innovative approach and influential backers, Molbio is well-positioned to drive significant change in the healthcare industry.

Taxonomy: Molecular diagnostics, Real-time PCR, Lab equipment, Medical devices, Point-of-care testing, Innovation, Microfluidics, Medical technology

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $85.00M 2
Temasek Holdings Motilal Oswal Private Equity
26 Sep 2022
Private Equity Round INR2.40B 1
Motilal Oswal Private Equity
05 Mar 2020

Molbio Diagnostics Alternatives & Competitors

Molbio Diagnostics vs
BIOPIX DNA TECHNOLOGY S.A.
BIOPIX DNA TECHNOLOGY S.A. Greece

Diagnostic solutions on the front lines of healthcare, enabling lab-quality testing anytime, anywher...

Seed
16 employees
Biotechnology, Health Care
Compare Molbio Diagnostics vs BIOPIX DNA TECHNOLOGY S.A.
Molbio Diagnostics vs
Blueprint Genetics
Blueprint Genetics Finland

Blueprint Genetics is a genetic diagnostics company focused on inherited diseases. We provide world-...

Debt Financing
240 employees
Biotechnology, Health Care
Compare Molbio Diagnostics vs Blueprint Genetics
Molbio Diagnostics vs
SIMPLEX QUANTUM, Inc.
SIMPLEX QUANTUM, Inc. Japan

Simplex Quantum, Inc. Create/implement artificial intelligence throughout global medical domains.

Series A
9 employees
AI, Health Care
Compare Molbio Diagnostics vs SIMPLEX QUANTUM, Inc.

FAQ About Molbio Diagnostics

Molbio is a disruptor in the global healthcare landscape, shifting existing paradigms in point-of-care diagnostics. With a vision focused on universalizing access to precise, rapid and cost-effective healthcare technologies, Molbio is at the forefront of providing cutting-edge solutions for quality...
Molbio Diagnostics was founded in 2000.
Molbio Diagnostics is headquartered in Verna, India.
Molbio Diagnostics operates in the following industries: Biotechnology, Health Care, Manufacturing, Medical Devices.
Molbio Diagnostics has approximately 588 employees.
Molbio Diagnostics has completed 2 funding rounds, raising a total of $2.49B. The latest funding stage is Series Unknown.
Top alternatives and competitors to Molbio Diagnostics include BIOPIX DNA TECHNOLOGY S.A., Blueprint Genetics, SIMPLEX QUANTUM, Inc., Zalgen, Euroimmun. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Molbio Diagnostics and BIOPIX DNA TECHNOLOGY S.A. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Molbio Diagnostics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy